Clinical Trials Directory

Trials / Completed

CompletedNCT00212056

Japan-Working Groups of Acute Myocardial Infarction for the Reduction of Necrotic Damage by ANP

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
National Cerebral and Cardiovascular Center, Japan · Academic / Other
Sex
All
Age
20 Years – 79 Years
Healthy volunteers
Not accepted

Summary

To evaluate whether ANP as an adjunctive therapy for AMI reduces myocardial infarct size and improves regional wall motion.

Detailed description

The benefits of percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) are limited by reperfusion injury. In animal models, atrial natriuretic peptide (ANP) reduces infarct size, so the Japan-Working groups of acute myocardial Infarction for the reduction of Necrotic Damage by ANP(J-WINDANP) designed a prospective, randomized, multicenter study, to evaluate whether ANP as an adjunctive therapy for AMI reduces myocardial infarct size and improves regional wall motion. Twenty hospitals in Japan will participate in the J-WIND-ANP study. Patients with AMI who are candidates for PCI are randomly allocated to receive either intravenous ANP or placebo administration. The primary end-points are (1) estimated infarct size (Σcreatine kinase and troponin T) and (2) left ventricular function (left ventriculograms). Single nucleotide polymorphisms (SNPs) that may be associated with the function of ANP and susceptibility of AMI will be examined. Furthermore, a data mining method will be used to design the optimal combinational therapy for post-MI patients. J-WIND-ANP will provide important data on the effects of ANP as an adjunct to PCI for AMI and the SNPs information will open the field of tailor-made therapy. The optimal therapeutic drug combination will also be determined for post-MI patients.

Conditions

Interventions

TypeNameDescription
DRUGANP(hANP)0∙025 μg/kg per min for 3 days(intravenous)
DRUGControlplacebo

Timeline

Start date
2001-10-01
Completion
2005-12-01
First posted
2005-09-21
Last updated
2007-11-01

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00212056. Inclusion in this directory is not an endorsement.